Skip to main content

Table 1 Demographic and tumor characteristic

From: Late term tolerance in head neck cancer patients irradiated in the IMRT era

Parameters

LRC, >12mo FU

N patients

707

Gender (f: m)

25%:75%

Mean age (range)

62 (39-91) years

Mean/Median FU (range)

41/35 (15-124) months

Diagnosis

 

Unknown

19 (3%)

Central oropharynx

96 (14%)

Lateral oropharynx

149 (21%)

Hypopharynx

69 (10%)

Oral cavity

111 (16%)

Nasopharynx

51 (7%)

Larynx

90 (13%)

Sinonasal

40 (5%)

Parotid gland

36 (5%)

Skin

33 (5%)

Nasal

10 (1%)

Others

3 (3%)

Treatment (dose)

 

Primary IMRT (66-72 Gy, 2.0-2.2 Gy/f)

55% (n=388)

Postoperative IMRT (60-66 Gy, 2.0 Gy/f)

45% (n=319)

T

 

1

17%

2

34%

3

20%

4

26%

Unknown

3%

N stage

 

Recurrence

2%

NO

32%

N1-2b

45%

N2c

17%

N3

4%

Total gross tumor volume (n=388)

 

Mean (range)

62 cc (1-217)

1-15 cc

115

16-70 cc

202

71-130 cc

63

>130 cc

8

Conc. systemic therapy

 

None

15%

Cisplatin only

62%

Cetuximab only

16%

Cisplatin switched to Cetuximab

7%

Induction chemotherapy

3%